Search results
Results from the WOW.Com Content Network
Mortality at 60 days was the primary endpoint. The calculated sample size was 331 patients with an intent to show a 20% reduction in absolute mortality in the ECMO group. The main secondary endpoint was treatment failure – cross-over to ECMO due to refractory hypoxemia or death in the control group and death in the ECMO group.
Acute respiratory distress syndrome was first described in 1967 by Ashbaugh et al. [10] [50] Initially there was no clearly established definition, which resulted in controversy regarding the incidence and death of ARDS. In 1988, an expanded definition was proposed, which quantified physiologic respiratory impairment.
For premium support please call: 800-290-4726 more ways to reach us
Similarly as with adults ECMO is only indicated if reversal of the pathology for example with cardiac transplantation, is feasible. [27] When it comes to the consideration of the withdrawal of ECMO, unlike in adult populations parents are encouraged to make the final decision with guidance from the treating physicians.
For premium support please call: 800-290-4726 more ways to reach us
It is often impossible to distinguish TRALI from acute respiratory distress syndrome (ARDS). The typical presentation of TRALI is the sudden development of shortness of breath, severe hypoxemia (O 2 saturation <90% in room air), low blood pressure, and fever that develop within 6 hours after transfusion and usually resolve with supportive care within 48 to 96 hours.
It has been revealed that patients with ARDS that show DAD on histology are at a high mortality rate of 71.9% compared to 45.5% in patients with ARDS but without DAD. [12] Of the patients who succumb to ARDS, the most common cause of death is septic shock with multi organ dysfunction syndrome.
At least three cancers with high mortality risk impact Black men disproportionately. Cancer deaths among men could potentially be on […] Cancer deaths in men are expected to rise 93% by 2050.